DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q1 2016. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $65,000 | -18.8% | 16,364 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $80,000 | -20.0% | 16,364 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $100,000 | +5.3% | 16,364 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $95,000 | -56.8% | 16,364 | 0.0% | 0.00% | -66.7% |
| Q4 2018 | $220,000 | -30.8% | 16,364 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $318,000 | -26.7% | 16,364 | -3.5% | 0.00% | -20.0% |
| Q2 2018 | $434,000 | +26.9% | 16,964 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $342,000 | +8.6% | 16,964 | +8.1% | 0.00% | 0.0% |
| Q4 2017 | $315,000 | -3.1% | 15,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $325,000 | +40.1% | 15,700 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $232,000 | -7.2% | 15,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $250,000 | +26.3% | 15,700 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $198,000 | -55.0% | 15,700 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $440,000 | -20.0% | 15,700 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $550,000 | +697.1% | 15,700 | +528.0% | 0.01% | +600.0% |
| Q1 2016 | $69,000 | -81.8% | 2,500 | -82.0% | 0.00% | -75.0% |
| Q4 2014 | $380,000 | – | 13,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |